S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
OTCMKTS:TSOI

Therapeutic Solutions International (TSOI) Stock Forecast, Price & News

$0.0017
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.0014
▼
$0.0018
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.02
Volume
8.21 million shs
Average Volume
12.50 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort Interest

TSOI stock logo

About Therapeutic Solutions International (OTCMKTS:TSOI) Stock

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.

TSOI Price History

TSOI Stock News Headlines

September 29, 2023 | finance.yahoo.com
Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
September 18, 2023 | finance.yahoo.com
Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board
September 29, 2023 | Behind the Markets (Ad)
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
September 15, 2023 | finance.yahoo.com
Therapeutic Solutions International Subsidiary Discloses Potential Solution to Immunotherapy Resistance in Cancer by "Healing Tumor" Before Killing It
September 12, 2023 | markets.businessinsider.com
What 6 Analyst Ratings Have To Say About Black Diamond Therapeutic
September 11, 2023 | finance.yahoo.com
Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia
August 21, 2023 | finance.yahoo.com
FloraStilbene™ Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast Cancer
August 16, 2023 | finance.yahoo.com
Therapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical Trial
September 29, 2023 | Investor Place Media (Ad)
Elon Musk May Have Just Changed Everything
Quantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. 
July 31, 2023 | finance.yahoo.com
Therapeutic Solutions International Prevention Subsidiary Campbell Neurosciences Receives Notice of Allowance on Suicide Prevention Drug Candidate
July 18, 2023 | finance.yahoo.com
Therapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene™
July 12, 2023 | finance.yahoo.com
Therapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal Dementia
July 8, 2023 | benzinga.com
Aion Therapeutic Announces Director Resignation
June 28, 2023 | finance.yahoo.com
Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
June 28, 2023 | finance.yahoo.com
Microba Commences Phase I Clinical Trial for IBD Therapeutic
June 26, 2023 | finance.yahoo.com
Therapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress Syndrome
June 19, 2023 | wnewsj.com
Bales talks Therapeutic Riding Camp at Rotary meeting
June 16, 2023 | msn.com
Carroll County Farm Museum hosts Therapeutic Recreation Day for individuals with disabilities
June 15, 2023 | finance.yahoo.com
Global Therapeutic Respiratory Devices Market Report 2023: Rising Prevalence of Respiratory Diseases Driving Growth
June 9, 2023 | finance.yahoo.com
Pruritus Therapeutic Global Market Report 2023
June 7, 2023 | msn.com
Therapeutic camp for kids offered in Sulphur
June 6, 2023 | benzinga.com
PharmStars Announces "Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface" Theme for its Fall 2023 Accelerator
May 25, 2023 | finance.yahoo.com
Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells
May 22, 2023 | finance.yahoo.com
Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses
May 15, 2023 | finance.yahoo.com
Therapeutic Solutions International Spin-Off Res Nova Bio Partners with Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene™
May 11, 2023 | marketwatch.com
2030, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market: Growth & Statistics
May 9, 2023 | msn.com
Recap: Black Diamond Therapeutic Q1 Earnings
See More Headlines
Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

TSOI Company Calendar

Today
9/29/2023
Next Earnings (Estimated)
11/17/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TSOI
CUSIP
883378101
CIK
1419051
Web
therapeuticsolutionsint.com
Phone
(760) 295-7208
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Timothy George Dixon (Age 65)
    Chairman, CEO, Pres & CFO
    Comp: $240k
  • Dr. Feng Lin M.D. (Age 52)
    Ph.D., Chief Scientific Officer
  • Dr. James Drew Veltmeyer M.D. (Age 57)
    Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board
  • Ms. Famela Ramos (Age 46)
    VP of Bus. Devel.
  • Ms. Serena Robella
    Director of Sales

Key Competitors

View All Competitors













TSOI Stock - Frequently Asked Questions

How have TSOI shares performed in 2023?

Therapeutic Solutions International's stock was trading at $0.0060 at the beginning of the year. Since then, TSOI stock has decreased by 71.7% and is now trading at $0.0017.
View the best growth stocks for 2023 here.

Are investors shorting Therapeutic Solutions International?

Therapeutic Solutions International saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 131,200 shares, a decrease of 50.7% from the August 31st total of 266,100 shares. Based on an average trading volume of 17,776,900 shares, the days-to-cover ratio is presently 0.0 days.
View Therapeutic Solutions International's Short Interest.

When is Therapeutic Solutions International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 17th 2023.
View our TSOI earnings forecast.

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD).

What is Therapeutic Solutions International's stock symbol?

Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI."

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Therapeutic Solutions International's stock price today?

One share of TSOI stock can currently be purchased for approximately $0.00.

How can I contact Therapeutic Solutions International?

Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The official website for the company is therapeuticsolutionsint.com. The company can be reached via phone at (760) 295-7208.

This page (OTCMKTS:TSOI) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -